Welcome to Alturas Analytics
Founded in 2000, Alturas Analytics was launched by a core team of bioanalytical experts driven to create a premier contract research organization (CRO) focused on HPLC-MS/MS bioanalysis. The team made a commitment to unmatched quality science, excellent customer service, and private ownership that is still upheld today.
President and co-founder Robin Woods previously contributed to the foundation and success of two environmental testing laboratories. Robin was pleased to provide her extensive experience and business acumen to Alturas Analytics, Inc. With an appointment to the Idaho Economic Advisory Council, membership on the Higher Education Research Council, and membership on the Idaho State Board of Education, Robin has broad foundational experience to lead the business through sustained growth.
Dr. Shane Needham, co-founder, provided the business with LC-MS/MS bioanalytical expertise. A former scientist at Pfizer, Dr. Needham acquired extensive experience with the first mass spectrometer in the industry, and has continually demonstrated a proclivity to advance bioanalytical methods and applications in chromatography and mass spectrometry.
Alturas is a privately owned company, and as such, enjoys the freedom to focus on fostering strong and lasting relationships with sponsors while retaining the flexibility needed to accommodate unique needs as they arise. From scientific operations to quality assurance, the Alturas staff has the skills and experience to adapt to changing timelines and rapid turnarounds for sample analysis and data delivery.
With an increase in the development of highly specific and targeted drugs, Alturas is prepared to address the demand with the latest technology teamed with knowledge and experience. All of this in an innovative, purpose-built laboratory facility situated in idyllic Moscow, Idaho, USA.
The Pacific Northwest affords many luxuries and a quality of life that is hard to come by elsewhere, and close proximity to two major research universities, major highways and interstate thoroughfares in combination with two local, dedicated airports keep Alturas well connected to the rest of the world. Alturas enjoys working with a diverse clientele, ranging from virtual startups to many of the most dominant pharmaceutical, biotechnology and medical device manufacturers in the world.
Alturas has a long-standing dedication to intensive research and reserves resources for the development of new bioanalytical applications and technologies, publications, presentations, and conference attendance. Among other past contributions to industry research, Alturas pioneered technology for use with bioanalytically challenging translucent fluids extracted from spotted cards. Alturas continues to lead the industry into the future.
Commitment to excellence in all things is reflected in those that have joined the Alturas ranks over the years, and this combined vision and dedication to providing the best service possible yields strong, well-managed growth that will continue into the future.